• <ul id="qe0qg"></ul>
    <ul id="qe0qg"><sup id="qe0qg"></sup></ul>
  • <fieldset id="qe0qg"><menu id="qe0qg"></menu></fieldset>
  • <strike id="qe0qg"></strike>
  • <ul id="qe0qg"></ul>
    <strike id="qe0qg"></strike>
    豪森藥業(yè)
    • Overview
    • 1995 Initial establishment
      A principal subsidiary of Hansoh Pharma (03692.HK)
      7
      Launched innovative drugs
      Top 100
      Pharmaceutical companies worldwide
      Top 3
      China's best Industrial enterprises in pharmaceutical R&D pipeline

    Therapy Areas

    • Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      We focus on the develoment of new drugs in the field of common and hostile cancers.Our innovative medicine programs in clinical trials include HS-20106 injection, HS-20105 injection, HS-20117 injection, HS-10516 capsules, HS-10382 tablets, HS-10370 tablets, HS-10502 tablets, HS-10365 capsules, HS-20089 injection, HS-20093 injection, HS-10352 tablets, HS-10241 tablets, etc.
      More +
    • Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      We focus on the development of new drugs in the fields of antiviral, anti-complex bacterial infection and anti-fungal infection. Our innovative medicine programs in clinical trials includeCitric Acid Erythorbate tablets, etc.
      More +
    • CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      We focus on the development of new drugs in the fields of psychiatric and neurological disorders.Our innovative medicine programs in clinical trials include HS-10380 tablets, HS-10506 tablets, HS-10353 capsules, HS-10509 tablets, etc.
      More +
    • Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      We focus on the development of new drugs in the field of metabolic diseases such as diabetes and obesity. Our innovative medicine programs in clinical trials include HS-10511 tablets, HS-20094 injection, HS-10384 tablets, HS-10518 capsules, HS-10390 tablets, HS-10501 tablets, and HS-10398 capsules, etc.
      More +
    • Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      We focus on the development of new drugs in the field of autoimmune diseases. Our innovative medicine programs in clinical trials includeHS-10374 tablets etc.
      More +
    R&D
    Innovation
    Jiangsu Hansoh Pharma Research Institute
    Jiangsu Hansoh Pharma Research Institute
    More
    Jiangsu Hansoh Pharma Administrative R&D Center
    Jiangsu Hansoh Pharma Administrative R&D Center
    More
    • Substantial investment on R&D
      In 2024, R&D expenditure was RMB2,702 million, and accounted for 22.0% of the revenue.
    • Competitive R&D pipeline
      More than 60 clinical trials of innovative drug candidates being investigated, covering 40 innovative drug candidates.
    • Highly efficient capability to discover innovative drugs
      The R&D pipeline covers peptides , small molecules, biologics, ADC drugs, siRNAs, and more.
    A broader world, let's discover together
    Join Hansoh Pharma +
    Work with us
    We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
    Join Hansoh Pharma +
    主站蜘蛛池模板: 亚洲AV永久精品爱情岛论坛| 国产综合精品一区二区三区| 精品国产乱码久久久久久1区2区 | 国产成人精品无人区一区| 99九九精品免费视频观看| 亚洲国产精品无码久久久不卡| 国产AⅤ精品一区二区三区久久| 国产精品视频永久免费播放| 亚洲精品国产精品国自产观看 | 婷婷国产成人精品一区二| 在线人成精品免费视频| 国精品无码一区二区三区在线 | 国产日韩高清三级精品人成| 久久99国产精品久久99| 国产第一福利精品导航| 国产成人精品免费久久久久| 精品久久久久久无码专区不卡| 最新国产精品无码| 国产精品亚洲精品日韩已满| 最新精品露脸国产在线 | 精品无人区一区二区三区| 午夜成人精品福利网站在线观看 | 亚洲精品欧美综合在线| 国产成人精品男人的天堂538| 精品三级AV无码一区| 久久精品毛片免费观看| 嫩草伊人久久精品少妇AV| 无码精品国产VA在线观看| 亚洲AV永久青草无码精品| 久久精品黄AA片一区二区三区| 老司机午夜精品视频资源| 日韩精品无码一区二区三区免费| 伊在人亚洲香蕉精品区麻豆| 亚洲精品第一国产综合精品99| 人妻少妇看A偷人无码精品视频| 日韩精品毛片| 中文精品99久久国产 | 亚洲午夜久久久精品影院| 老司机91精品网站在线观看| 在线电影国产精品| 国产欧美日韩综合精品一区二区三区 |